UCP3 and fatty liver disease: Choi et al. demonstrated that the overexpression of UCP3 in skeletal muscle protected mice from HFD-induced defects, including increased whole-body fat mass, hepatic steatosis, and insulin resistance, through an increase in the whole-body energy expenditure (51).